Theraclone Sciences Secures $14 Million in Additional Financing

$8 million in equity is committed from existing investors ARCH Venture Partners, Canaan Partners, MPM Capital, Healthcare Ventures, Alexandria Real Estate Equities, Amgen Ventures, Versant Ventures and Zenyaku Kogyo in a Series B Extension, bringing the total round to $50 million.

http://eon.businesswire.com/news/eon/20130325005236/en/Theraclone-Sciences-Secures-14-Million-Additional-Financing